• Belinostat (PXD101): Strategic Epigenetic Modulation in Canc

  2026-05-07

  This thought-leadership article delivers a mechanistic and translational roadmap for leveraging Belinostat (PXD101) in cancer research. By integrating rigorous experimental rationale, competitive intelligence, and state-of-the-art in vitro evaluation frameworks, it provides actionable guidance for translational scientists focused on histone deacetylase inhibition in bladder and prostate cancer models.

• Deferoxamine Mesylate: Advanced Workflows in Iron Chelation

  2026-05-07

  Deferoxamine mesylate stands out as an iron-chelating agent for precise modulation of iron metabolism, oxidative stress, and hypoxia signaling. This article delivers actionable protocols, troubleshooting insights, and comparative advantages for researchers leveraging Deferoxamine mesylate in translational oncology, wound healing, and ferroptosis studies.

• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-05-06

  This study identifies a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c demonstrating potent in vitro and in vivo efficacy relevant to metabolic, allergic, and cancerous conditions. The findings highlight the therapeutic potential of targeting PDK4 for diseases characterized by metabolic dysregulation and provide a validated scaffold for future drug development.

• Lipid Scrambling Suppresses Ferroptosis and Boosts Tumor Imm

  2026-05-06

  Yang et al. uncover TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis at the plasma membrane, demonstrating that its inhibition potentiates ferroptotic cell death and enhances tumor immune rejection. This work refines our understanding of cell death execution and suggests new strategies for combining ferroptosis modulation with immunotherapy.

• Pronase E Protease Mixture: Optimizing Biomedical Workflows

  2026-05-05

  Pronase E’s broad-spectrum protease activity streamlines even the most challenging protein sample preparation tasks, enhancing reproducibility in proteomics and molecular biology. This guide translates recent research breakthroughs into actionable protocols, troubleshooting tips, and advanced application strategies for maximizing your results with this versatile enzyme.

• Thiothixene and the New Frontier: Assay Design for Dual Neur

  2026-05-05

  Explore how Thiothixene, a typical antipsychotic agent, is redefining neuroimmune assay workflows through its dual action on dopamine signaling and efferocytosis. This article uniquely bridges genetic insights from schizophrenia research with advanced in vitro assay optimization.

• Organic Cation Transporter Response to Xenobiotics in Aedes

  2026-05-04

  Kennel and Rouhier’s study investigates how Aedes aegypti mosquitoes physiologically and transcriptionally respond to injected xenobiotic dyes, including Olsalazine Sodium. Their results reveal that while transporter gene expression is minimally altered, the chemical structure of xenobiotics significantly impacts excretion dynamics and mosquito mortality, offering new insights for vector control strategies.

• Perphenazine (SKU B6157): Data-Backed Solutions for Cell Ass

  2026-05-04

  This article provides scenario-driven, evidence-based workflow guidance for using Perphenazine (SKU B6157) in cell viability, proliferation, and cytotoxicity assays. Designed for biomedical researchers and lab technicians, it addresses reproducibility, protocol optimization, and vendor reliability—highlighting APExBIO’s Perphenazine as a data-driven choice for advanced neuropharmacology and host-pathogen research.

• Docetaxel in Translational Oncology: Mechanisms, Resistance,

  2026-05-03

  This thought-leadership article explores how Docetaxel’s microtubule stabilization mechanism underpins its efficacy in cancer chemotherapy research, with a special focus on the emerging challenge of chemoresistance driven by microbiome alterations. We integrate mechanistic insights, strategic guidance for researchers, and evidence-based discussion, including new findings on the NF-κB-IL6-STAT3 axis in resistance. By referencing leading literature and product intelligence, we position APExBIO’s Docetaxel as a cornerstone for advanced translational models, bridging mechanistic depth with experimental strategy.

• Organic Cation Transporters in Aedes aegypti: Response to Dy

  2026-05-02

  Kennel and Rouhier (2025) investigated how Aedes aegypti mosquitoes process xenobiotic dyes, focusing on the molecular and physiological responses to compounds such as Alizarin Yellow and Olsalazine Sodium. Their findings reveal that the chemical structure of xenobiotics, rather than changes in transporter gene expression, predominantly determines excretion dynamics and mortality, providing new insights into mosquito detoxification and control strategies.

• Perospirone Inhibits Kv1.5 Channels: Cardiovascular Implicat

  2026-05-01

  A recent study demonstrates that perospirone (SM-9018 free base), a second-generation antipsychotic, exerts previously unrecognized off-target inhibition of voltage-gated Kv1.5 potassium channels in coronary arterial smooth muscle cells. This finding expands the mechanistic understanding of perospirone and highlights potential cardiovascular considerations in its use for neuropsychiatric research models.

• Structural and Chemical Advances in Silybin and Silymarin Re

  2026-05-01

  The reference review by Křen et al. systematically dissects the chemistry, isolation, stereochemistry, and derivative synthesis of silybin, the principal flavonolignan in silymarin. This comprehensive analysis provides a rigorous framework for both fundamental and translational researchers, particularly those focused on optimizing silybin’s bioactive properties for liver disease, metabolic modulation, and antioxidant research.

• Perospirone Inhibits Vascular Kv1.5 Channels: Implications f

  2026-04-30

  This study reveals that Perospirone (SM-9018 free base), beyond its established serotonergic and dopaminergic antagonism, acts as a concentration-dependent inhibitor of vascular Kv1.5 potassium channels. These results highlight an unanticipated off-target effect, underscoring the need to consider cardiovascular implications when deploying Perospirone in neuropsychiatric disorder research models.

• Xenobiotic Transporter Response to Dye Exposure in Aedes aeg

  2026-04-30

  Kennel and Rouhier (2025) investigated how Aedes aegypti mosquitoes process and excrete xenobiotic dyes, focusing on the expression of putative organic cation transporters (OCTs/Ns) and physiological responses. Their findings reveal that molecular structure, rather than transporter gene induction, governs excretion and mortality, highlighting new directions for mosquito control strategies.

• Distinct Apoptotic Pathways Induced by Candida krusei in Bov

  2026-04-29

  This study reveals that Candida krusei triggers apoptosis in bovine mammary epithelial cells (BMECs) via two distinct signaling routes, depending on whether the yeast or hypha phase is present. The findings offer new mechanistic insights into fungal mastitis and suggest precise intervention points for apoptosis inhibition.

681 records 13/46 page Previous Next First page 上5页 1112131415 下5页 Last page